What Does the Future Hold for Pharmacy?
Being Part of the Solution
Health Innovations Meeting
Texas Medical Center
September 2016
Linda Garrelts MacLean
Clinical Professor and Vice Dean
Spokane, WA
[email protected]
509-995-4926
WHAT DOES THE FUTURE HOLD FOR PHARMACY:
IMPLICATIONS FOR COLLEGES AND SCHOOLS OF PHARMACY
What are the top 10
emerging healthcare
trends?
Who does the trend affect?
What are implications for patients and
providers, including pharmacists?
What are the implications for pharmacy
education?
Drivers and Forces for
Pharmacy Practice
Transformation
Barriers to implementing innovative
pharmacy services?
Strategies to overcome challenges?
Drivers and Forces for
Pharmacy Practice
Transformation
The Affordable Care Act influence on
transformation?
Role of collaborative drug therapy
agreements on transformation?
National Perspectives and
Practice Advancement
National Alliance of State Pharmacy
Associations
 NASPA’s Pharmacist Collaborative Practice Agreements: Key Elements
for Legislative and Regulatory Authority (http://naspa.us/wpcontent/uploads/2015/07/CPA-Workgroup-Report-FINAL.pdf )
 Oregon
 California
 Washingon
National Perspectives and
Practice Advancement
American Pharmacists Association
 www.pharmacistsprovidecare.com
 http://avalerehealth.net/
Embracing
“Future Practice”
Now
Increasing Access to Quality Patient
Care in Community Pharmacies for Minor
Illnesses in Washington State
Community Pharmacists Caring for Patients with
Minor Ailments and Common Conditions
Objective: As states implement the Triple Aim
and seek to ensure access to quality care,
innovative delivery models are being evaluated
on the premise that improved access to care for
patients in sites such as community pharmacies
will result in more rapid assessment and
initiation of therapy, improving patient health
outcomes.
Now: A 3-phase analysis is being undertaken.
Minor Ailments and Common
Conditions Research
Care being provided in the community
pharmacies.
Collaborative drug therapy agreements
being used.
Pharmacies participating.
Encounters and documentation.
Minor Ailments and Common
Conditions Research
Phase One
 feasibility and sustainability
Phase Two
 cost
Phase Three
 quality
Pharmacy Education:
CREATING FUTURE LEADERS
QUESTIONS?
Used with permission from WSPA